Methods of diagnosing or treating prostate cancer using the ERG gene, alone or in combination with other over or under expressed genes in prostate cancer

Details for Australian Patent Application No. 2011213720 (hide)

Owner The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.

Inventors Petrovics, Gyorgy; Srivastava, Shiv

Agent Griffith Hack

Pub. Number AU-A-2011213720

Parent 2005245815

Filing date 17 August 2011

Wipo publication date 8 September 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

1 September 2011 Complete Application Filed

8 September 2011 Application Open to Public Inspection

  Published as AU-A-2011213720

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011213721-Antibody formulation in histidine-acetate buffer

2011213719-Nanoemulsion compositions